MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer

Oncogene

Volumn 32, Issue 35, 2013, Pages 4139-4147

  Hudson, R S ^a   Yi, M ^b   Esposito, D ^b   Glynn, S A ^a   Starks, A M ^a   Yang, Y ^a   Schetter, A J ^a   Watkins, S K ^c   Hurwitz, A A ^c   Dorsey, T H ^a   Stephens, R M ^b   Croce, C M ^d   Ambs, S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

apoptosis; disease outcome; microRNA; prostate cancer

Indexed keywords

AGAR; CASPASE 7; MICRORNA; MICRORNA 106B 25; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; BIOINFORMATICS; BONE MATRIX; CANCER CELL; CANCER GROWTH; CANCER RECURRENCE; CELL STRAIN LNCAP; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FOCAL ADHESION; GENE EXPRESSION; HAZARD RATIO; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION; MALE; MOUSE; NONHUMAN; ONCOGENE; OUTCOME ASSESSMENT; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; RECURRENT DISEASE; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; CASPASE 7; CELL LINE, TUMOR; EXTRACELLULAR MATRIX; FOCAL ADHESIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS;

EID: 84883487767     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.424     Document Type: Article

References (35)

1. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008; 455: 64-71.
2. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-15529.
3. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-833.
4. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-647.
5. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
6. He L, He X, Lim LP, de SE, Xuan Z, Liang Y et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-1134.
7. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147-152.
8. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40: 3-50.
9. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008; 322: 1695-1699.
10. Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, Chowdhury WH et al. miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res 2009; 69: 7165-7169.
11. Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, Hobbs RM et al. Identification of the miR-106bB25 microRNA cluster as a proto-oncogenic PTENtargeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 2010; 3: ra29.
12. Catto JW, Alcaraz A, Bjartell AS, De Vere WR, Evans CP, Fussel S et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 2011; 59: 671-681.
13. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008; 68: 6162-6170.
14. Szczyrba J, Loprich E, Wach S, Jung V, Unteregger G, Barth S et al. The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res 2010; 8: 529-538.
15. Martens-Uzunova ES, Jalava SE, Dits NF, van Leenders GJ, Moller S, Trapman J et al. Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer. Oncogene 2011; 31: 978-991.
16. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A et al. Micro-RNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006; 103: 9136-9141.
17. Ren B, Yu G, Tseng GC, Cieply K, Gavel T, Nelson J et al. MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene 2006; 25: 1090-1098.
18. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de MI et al. E2F1-Regulated MicroRNAs Impair TGFbeta-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer. Cancer Cell 2008; 13: 272-286.
19. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 2008; 28: 2167-2174.
20. Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009; 136: 1689-1700.
21. Li B, Shi XB, Nori D, Chao CK, Chen AM, Valicenti R et al. Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate 2011; 71: 567-574.
22. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010; 18: 11-22.
23. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995; 92: 3439-3443.
24. Sboner A, Demichelis F, Calza S, Pawitan Y, Setlur SR, Hoshida Y et al. Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics 2010; 3: 8.
25. Fang L, Deng Z, Shatseva T, Yang J, Peng C, Du WW et al. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 2011; 30: 806-821.
26. Yu J, Wang F, Yang GH, Wang FL, Ma YN, Du ZW et al. Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem Biophys Res Commun 2006; 349: 59-68.
27. Jalava SE, Urbanucci A, Latonen L, Waltering KK, Sahu B, Jänne OA et al. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer. Oncogene 2012; 31: 4460-4471.
28. Trompeter HI, Abbad H, Iwaniuk KM, Hafner M, Renwick N, Tuschl T et al. MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS ONE 2011; 6: e16138.
29. Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG et al. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009; 100: 1234-1242.
30. Gocek E, Wang X, Liu X, Liu CG, Studzinski GP. MicroRNA-32 Upregulation by 1,25-Dihydroxyvitamin D3 in Human Myeloid Leukemia Cells Leads to Bim Targeting and Inhibition of AraC-Induced Apoptosis. Cancer Res 2011; 71: 6230-6239.
31. Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M et al. Apoptosis and cancer: mutations within caspase genes. J Med Genet 2009; 46: 497-510.
32. Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan A-C et al. The miR-106b-25 cluster targets Smad7, activates TGF-b signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 2012; 31: 5162-5171.
33. Petrocca F, Vecchione A, Croce CM. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 2008; 68: 8191-8194.
34. Reginato MJ, Mills KR, Paulus JK, Lynch DK, Sgroi DC, Debnath J et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 2003; 5: 733-740.
35. Prueitt RL, Yi M, Hudson RS, Wallace TA, Howe TM, Yfantis HG et al. Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 2008; 68: 1152-1164.